glp-1 latest news drugs promise wider health benefits, but experts urge caution on use 🚨 Big news for people

By coupling GLP1-R agonist and GIP agonist together (seen in Tirzepatide), reduced reward-seeking behavior induced by the former may be strengthened by the enhanced mTOR effect of the latter, reinforcing neural circuits involved in executive control and decision-making, potentially counteracting the dysregulated reward pathways seen in addiction (Figure 3) [46,51]

Seeing the steps laid out makes it easier to spot where to break the cycle

After kids, its a medicine my body needed, she says

Patients with diabetes and retinopathy should be monitored closely, as rapid improvement in glucose control may be associated with temporary worsening of retinopathy

GLP-1 inhibits the secretion of IFN- and IL-4 by iNKT cell in a dose-dependent manner

The fix: When escalating to a new dose, consider temporarily shifting to evening injection for 1 to 2 weeks